We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$512M
AUM Growth
+$238M
Cap. Flow
+$1.67M
Cap. Flow %
0.33%
Top 10 Hldgs %
60.66%
Holding
62
New
15
Increased
14
Reduced
17
Closed
13

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$13.1M
2
LLY icon
Eli Lilly
LLY
+$8.03M
3
BMY icon
Bristol-Myers Squibb
BMY
+$5.54M
4
MRK icon
Merck
MRK
+$4.46M
5
CAH icon
Cardinal Health
CAH
+$3.8M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$7.99M
2
ISRG icon
Intuitive Surgical
ISRG
+$7.39M
3
BDX icon
Becton Dickinson
BDX
+$7.29M
4
A icon
Agilent Technologies
A
+$6.14M
5
FMS icon
Fresenius Medical Care
FMS
+$5.35M

Sector Composition

Rank Sector Weight
1 Healthcare 54.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIO icon
51
Bio-Rad Laboratories Class A
BIO
$9.48B
– –
-6,500
Closed -$3.71M
BNTX icon
52
BioNTech
BNTX
$23.4B
– –
-20,000
Closed -$2.18M
FMS icon
53
Fresenius Medical Care
FMS
$12.6B
– –
-145,000
Closed -$5.35M
GH icon
54
Guardant Health
GH
$22.2B
– –
-10,000
Closed -$1.53M
HAE icon
55
Haemonetics
HAE
$4.06B
– –
-25,000
Closed -$2.77M
INNV icon
56
InnovAge Holding
INNV
$1.41B
– –
-85,000
Closed -$2.19M
ISRG icon
57
Intuitive Surgical
ISRG
$142B
– –
-30,000
Closed -$7.39M
MRNA icon
58
Moderna
MRNA
$24.9B
– –
-15,000
Closed -$1.96M
QURE icon
59
uniQure
QURE
$3.13B
– –
-61,768
Closed -$2.08M
TMO icon
60
Thermo Fisher Scientific
TMO
$222B
– –
-17,500
Closed -$7.99M
VRTX icon
61
Vertex Pharmaceuticals
VRTX
$134B
– –
-15,000
Closed -$3.22M
PPD
62
DELISTED
PPD, Inc. Common Stock
PPD
– –
-110,000
Closed -$4.16M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q2 2021 Portfolio in Review

As of Q2 2021, Sivik Global Healthcare held 62 positions worth $512M, up 87% from $274M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Sivik Global Healthcare's Q2 2021 filing shows 15 new, 14 increased, 17 reduced and 13 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 100,000 shares worth $13.5M. The largest sale was Thermo Fisher Scientific, an estimated $7.99M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 99% a quarter earlier.

  • Sivik Global Healthcare's largest Q2 2021 buy was State Street SPDR S&P Biotech ETF: 100,000 shares worth $13.5M.
  • Sivik Global Healthcare added most to Johnson & Johnson in Q2 2021, an estimated $3.31M increase.
  • Sivik Global Healthcare's biggest Q2 2021 reduction was Agilent Technologies, cutting an estimated $6.14M.
  • Sivik Global Healthcare fully exited Thermo Fisher Scientific in Q2 2021, selling an estimated $7.99M.
  • Sivik Global Healthcare's ten largest holdings make up 61% of its $512M portfolio in Q2 2021.
  • Sivik Global Healthcare opened 15 new positions and closed 13 in Q2 2021.
  • Sivik Global Healthcare's portfolio value rose 87% quarter-over-quarter to $512M.

Based on Sivik Global Healthcare's 13F filing for Q2 2021, filed 10 Aug 2021.